Gabriel Théberge-Julien

发表

The interleukin-1β modulator gevokizumab reduces neointimal proliferation and improves reendothelialization in a rat carotid denudation model.

J. Tardif, F. Roubille, É. Rhéaume, 2014, Atherosclerosis.

Colchicine reduces lung injury in experimental acute respiratory distress syndrome

J. Tardif, É. Rhéaume, D. Rhainds, 2020, PloS one.

Expression, subcellular localization, and phosphorylation of MK5 in adult cardiac ventricular fibroblasts

J. Tardif, M. Gaestel, P. Sahadevan, 2020, bioRxiv.

Selection of peptides interfering with a ribosomal frameshift in the human immunodeficiency virus type 1.

N. Heveker, L. Brakier-Gingras, D. Dulude, 2008, RNA.

Beneficial Effects of Reconstituted High-Density Lipoprotein (rHDL) on Circulating CD34+ Cells in Patients after an Acute Coronary Syndrome

J. Tardif, C. Berry, M. Guertin, 2017, PloS one.

Adenylate cyclase type 9 antagonizes cAMP accumulation and regulates endothelial signaling involved in atheroprotection.

J. Tardif, M. Dubé, Camille Rosa, 2022, Cardiovascular research.

A single bout of high-intensity interval exercise does not increase endothelial or platelet microparticles in stable, physically fit men with coronary heart disease.

L. Bosquet, J. Tardif, T. Guiraud, 2013, The Canadian journal of cardiology.

The interleukin-1β modulator gevokizumab reduces neointimal proliferation and improves reendothelialization in a rat carotid denudation model.

J. Tardif, F. Roubille, É. Rhéaume, 2014, Atherosclerosis.